# Armata Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed May 13, 2026

- Company: [Armata Pharmaceuticals, Inc.](/companies/armp.md) (CIK 921114)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-13
- Accepted by EDGAR: May 13, 2026, 17:21 ET
- Period: not reported
- Accession: 0001104659-26-060384
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/921114/000110465926060384/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921114/000110465926060384/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921114/000110465926060384/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-060384. Last ingested by Listed: Nov 13, 2026, 16:13 ET. No prices; not investment advice.
